4.3 Article

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study

Related references

Note: Only part of the references are listed.
Review Psychology, Developmental

The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

David Coghill et al.

Summary: ADHD is a common neurodevelopmental disorder in children and adolescents, and timely interventions are a priority. However, current research reports and reviews on interventions for ADHD often lack consistency and are difficult to interpret. Clinicians need to consider methodological issues and gaps in the evidence when evaluating treatments for ADHD.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2023)

Article Clinical Neurology

Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder

J. K. Buitelaar et al.

Summary: This study examines the long-term use of methylphenidate in adolescents and young adults with ADHD and its effects on blood pressure and left ventricular mass. The results suggest that long-term methylphenidate use is associated with slight increases in systolic blood pressure and heart rate during the day, but does not significantly affect left ventricular mass.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Clinical Neurology

Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder

J. K. Buitelaar et al.

Summary: Long-term use of methylphenidate (MPH) in patients with ADHD is associated with slight increases in daytime systolic blood pressure and heart rate, but has no significant impact on blood pressure and left ventricular mass. Therefore, monitoring of blood pressure and heart rate during MPH treatment is recommended.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Review Behavioral Sciences

Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis

Sara Carucci et al.

Summary: The study reviewed the association of long-term MPH exposure with height, weight, and timing of puberty in ADHD individuals. MPH was found to have consistent significant effects on reducing height and weight, with more prominent impacts observed in the initial months of treatment. Limited data were available on the timing of puberty. Prospective studies are needed to further explore the underlying biological mechanisms and potential clinical implications.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Article Mathematical & Computational Biology

Using propensity scores to estimate effects of treatment initiation decisions: State of the science

Michael Webster-Clark et al.

Summary: Propensity score methods are effective in reducing bias from measured confounding in nonexperimental studies, leading to less biased treatment effect estimates. This methodology, formalized by Rosenbaum and Rubin in 1983, has been increasingly used in various scientific disciplines, particularly in making single treatment decisions between two therapeutic options. Propensity score analysis includes aspects such as alignment with the potential outcomes framework, implications for study design, estimation procedures, implementation options, and reporting.

STATISTICS IN MEDICINE (2021)

Article Behavioral Sciences

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

Stephen Faraone et al.

Summary: This study curated 208 empirically supported statements about ADHD based on strong evidence. These statements were endorsed by 80 authors from 27 countries and 6 continents, as well as 366 readers who agreed with the contents of the document. The meta-analysis findings provide firm statements about the nature, course, outcome causes, and treatments of ADHD, which can help reduce misconceptions and stigma.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)

Article Clinical Neurology

Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study

Le Gao et al.

Summary: Children and adolescents with ADHD who are treated with MPH may have a lower risk of all-cause poisoning, especially during prolonged medication use. The risk of poisoning is higher shortly before and after the first MPH prescription, but lower during subsequent exposure periods. The study suggests that longer-term use of MPH may be associated with a reduced risk of all-cause poisoning, although further research is needed.

CNS DRUGS (2021)

Article Public, Environmental & Occupational Health

Association between methylphenidate and risk of myocardial infarction: A multinational self-controlled case series study

Han Eol Jeong et al.

Summary: This multinational study found that although there was a positive association between initiating methylphenidate and the onset of myocardial infarction, the highest risk period was before its initiation.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Article Neurosciences

Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts

Zheng Chang et al.

BIOLOGICAL PSYCHIATRY (2020)

Review Behavioral Sciences

Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence

Helga Krinzinger et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)

Article Psychiatry

Association of Risk of Suicide Attempts With Methylphenidate Treatment

Kenneth K. C. Man et al.

JAMA PSYCHIATRY (2017)

Article Psychiatry

The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys

John Fayyad et al.

ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS (2017)

Article Pharmacology & Pharmacy

Stimulant medication effects on growth and bone age in children with attention-deficit/hyperactivity disorder: a prospective cohort study

Alison S. Poulton et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)

Article Psychology, Developmental

Stimulant ADHD medication and risk for substance abuse

Zheng Chang et al.

JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2014)

Article Pediatrics

Stimulant Treatment of ADHD and Cigarette Smoking: A Meta-Analysis

Erin N. Schoenfelder et al.

PEDIATRICS (2014)

Article Medicine, General & Internal

Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study

Qi Chen et al.

BMJ-BRITISH MEDICAL JOURNAL (2014)

Article Psychiatry

Stimulant Medication and Substance Use Outcomes A Meta-analysis

Kathryn L. Humphreys et al.

JAMA PSYCHIATRY (2013)

Article Psychology, Developmental

Long-term effects of methylphenidate transdermal delivery system treatment of ADHD on growth

Stephen V. Faraone et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)

Article Psychology, Clinical

Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD

BSG Molina et al.

JOURNAL OF ABNORMAL PSYCHOLOGY (2003)

Article Psychology, Developmental

Psychometric properties of the strengths and difficulties questionnaire

R Goodman

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)